focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSpectris Regulatory News (SXS)

Share Price Information for Spectris (SXS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 3,168.00
Bid: 3,578.00
Ask: 2,998.00
Change: -134.00 (-4.06%)
Spread: -580.00 (-16.21%)
Open: 3,286.00
High: 3,286.00
Low: 3,164.00
Prev. Close: 3,302.00
SXS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Divestment of Red Lion Controls

11 Dec 2023 17:00

RNS Number : 3924W
Spectris PLC
11 December 2023
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

Completion of portfolio rationalisation with divestment of Red Lion Controls

 

· Divestment of Red Lion Controls (Red Lion) for $345 million

· Servomex to be reported as part of Spectris Scientific following completion

· Launch of share buyback programme of up to £150 million

 

Divestment of Red Lion

 

11 December 2023 - Spectris plc (SXS: LSE) ('Spectris' or 'the Group' or 'the Company'), the expert in providing insight through precision measurement, today announces the sale of Red Lion Controls ('Red Lion') to HMS Networks (HMS) for $345 million (£286 million).

 

Red Lion provides industrial organisations innovative software and hardware solutions to access and connect disparate assets using the industrial ethernet and to enable visualisation of valuable data. For the 2022 financial year, Red Lion generated sales of £91.3 million, adjusted operating profit of £16.0 million and, as at 30 June 2023, the book value of Red Lion's gross assets was £105.5 million. The consideration for the sale will be settled in cash subject to customary adjustments for working capital, cash and debt and is subject to customary completion conditions and regulatory approvals, with completion expected to take place in the first half of 2024. After allowing for tax, the net proceeds from the sale are expected to be approximately $275 million (£228 million).

 

Portfolio rationalisation complete

 

This divestment increases the total net sale proceeds over the past 5 years to £1.2 billion and completes the portfolio rationalisation envisaged in 2019. Following completion, Servomex, which is currently reported alongside Red Lion as part of our 'Other' division, will be reported as part of the Spectris Scientific division, reflecting its position as a world leader in the provision of specialist premium gas and moisture analysis instruments and solutions.

 

Strong balance sheet provides capital allocation flexibility

 

The Group remains committed to driving sustainable organic growth, with significant investment in R&D, while continuing to use our strong balance sheet to compound growth through value-enhancing acquisitions, ranging from early-stage technologies and bolt-ons, to larger acquisitions, where we continue to maintain an active pipeline of opportunities. 

 

Having considered the future acquisition pipeline alongside our balance sheet position including the expected proceeds from the Red Lion divestment, we are today announcing a further share buyback programme of up to £150 million, with the first tranche of £50 million to commence before the end of this financial year. 

 

Andrew Heath, Chief Executive, said:

"Since 2019, we have transformed Spectris into a higher-quality, more resilient business, focused on attractive markets benefiting from a number of structural growth trends. Following today's announcement and with Servomex being reported as part of Spectris Scientific, we have two great premium precision measurement businesses with attractive growth trajectories, aligned to markets with a strong sustainability focus. I would like to thank the whole Red Lion team for their contribution to Spectris and wish them all well for the future."

 

Spectris will publish its full-year results for 2023 on 29 February 2024.

 

The person responsible for arranging the release of this announcement on behalf of Spectris is Rebecca Dunn, Company Secretary.

 

 

For and on behalf of Spectris plc

LEI Number: 213800Z4CO2CZO3M3T10

 

Contacts:

Spectris plc

Mathew Wootton

Investor Relations Director+44 7500 078880

 

 

 

Teneo

Martin Robinson/Giles Kernick

+44 20 7353 4200

 

About Spectris

Spectris combines precision with purpose, delivering progress for a more sustainable world. We provide critical insights to our customers through premium precision measurement solutions combined with technical expertise and deep domain knowledge. Precision is at the heart of what we do - our leading, high-tech instruments and software equip our customers to solve some of their greatest challenges to make the world cleaner, healthier and more productive. We are focused on two key divisions - Spectris Scientific and Spectris Dynamics, which are placed in technology-driven end markets, with strong fundamentals and attractive growth trajectories. We have leading market positions in premium segments and employ 7,500 people located in more than 30 countries, all united behind our purpose to deliver value beyond measure for all our stakeholders. For more information, visit www.spectris.com.

 

About HMS Networks

 

Headquartered in Sweden, with operations in 18 countries, HMS is a world leader in industrial information and communication technology providing a range of products that enable industrial equipment to communicate and share information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DISFFMFMFEDSEIE
Date   Source Headline
18th Oct 20226:02 pmRNSTransaction in Own Shares
18th Oct 20227:00 amRNSTransaction in Own Shares
17th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSTransaction in Own Shares
12th Oct 20225:42 pmRNSTransaction in Own Shares
11th Oct 20226:03 pmRNSTransaction in Own Shares
10th Oct 20225:39 pmRNSTransaction in Own Shares
10th Oct 20222:03 pmRNSDirector/PDMR Shareholding
10th Oct 20227:00 amRNSTransaction in Own Shares
7th Oct 20227:00 amRNSTransaction in Own Shares
6th Oct 20227:00 amRNSTransaction in Own Shares
4th Oct 20226:17 pmRNSTransaction in Own Shares
4th Oct 20227:00 amRNSTransaction in Own Shares
3rd Oct 202210:50 amRNSTotal Voting Rights
30th Sep 20226:30 pmRNSTransaction in Own Shares
30th Sep 202211:09 amRNSDirector Declaration
30th Sep 20227:00 amRNSTransaction in Own Shares
29th Sep 20227:00 amRNSTransaction in Own Shares
28th Sep 20227:00 amRNSTransaction in Own Shares
27th Sep 20227:00 amRNSTransaction in Own Shares
23rd Sep 20225:49 pmRNSTransaction in Own Shares
22nd Sep 20226:02 pmRNSTransaction in Own Shares
22nd Sep 20227:00 amRNSTransaction in Own Shares
21st Sep 20227:00 amRNSTransaction in Own Shares
16th Sep 20226:27 pmRNSTransaction in Own Shares
15th Sep 20226:41 pmRNSTransaction in Own Shares
15th Sep 20227:00 amRNSTransaction in Own Shares
14th Sep 20227:00 amRNSTransaction in Own Shares
13th Sep 20227:00 amRNSTransaction in Own Shares
9th Sep 20226:07 pmRNSTransaction in Own Shares
9th Sep 20229:59 amRNSTransaction in Own Shares
8th Sep 20224:42 pmRNSDirector/PDMR Shareholding
8th Sep 20227:00 amRNSTransaction in Own Shares
6th Sep 20226:15 pmRNSTransaction in Own Shares
6th Sep 20227:00 amRNSTransaction in Own Shares
5th Sep 20227:00 amRNSTransaction in Own Shares
2nd Sep 20229:33 amRNSAcquisition of Dytran Instruments completed
2nd Sep 20227:00 amRNSTransaction in Own Shares
1st Sep 20221:28 pmRNSTotal Voting Rights
31st Aug 20226:34 pmRNSTransaction in Own Shares
30th Aug 20225:58 pmRNSTransaction in Own Shares
30th Aug 20227:00 amRNSTransaction in Own Shares
26th Aug 20228:37 amRNSTransaction in Own Shares
24th Aug 20226:12 pmRNSTransaction in Own Shares
23rd Aug 20226:22 pmRNSTransaction in Own Shares
22nd Aug 20226:09 pmRNSTransaction in Own Shares
19th Aug 20226:02 pmRNSTransaction in Own Shares
19th Aug 20227:00 amRNSTransaction in Own Shares
18th Aug 20227:00 amRNSTransaction in Own Shares
17th Aug 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.